Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 981 entries
View as:

Clinical Characteristics and Analysis of Pituitary Complex and Rare Diseases

Phase: N/A Priority: Normal
NCT ID: NCT06435195 Org: User:
Start: 01/01/24 End: 12/31/26 Due: 12/31/27

Effects of Protein on Muscle, Gut Microbiota and Clinical Outcome in Patients With Lung Cancer-related Sarcopenia

Phase: N/A Priority: Normal
NCT ID: NCT05771207 Org: User:
Start: 03/31/23 End: 01/31/24 Due: 01/31/25

Clinical Evaluation Of Needle-based Confocal Laser Endomicroscopy in Cystic Tumors of the Pancreas

Phase: N/A Priority: Normal
NCT ID: NCT03182270 Org: User:
Start: 07/31/16 End: 12/31/21 Due: 12/31/22

Sirolimus in the Treatment of Refractory/Relapsed wAIHA

Phase: N/A Priority: Normal
NCT ID: NCT05925023 Org: User:
Start: 06/24/23 End: 12/31/25 Due: 12/31/26

MMP-9 Monitoring Particulate Cerebral Embolisation

Phase: N/A Priority: Normal
NCT ID: NCT02109120 Org: User:
Start: 02/29/12 End: 11/30/13 Due: 11/30/14

A Randomized Trial of rhTPO Versus Placebo for Low/Intermediate-1 Risk MDS With Thrombocytopenia

Phase: N/A Priority: Normal
NCT ID: NCT04324060 Org: User:
Start: 03/01/20 End: 12/01/22 Due: 12/01/23

Clinical、metabolomics and the Study of Intestinal Flora of Jinfeng Pills in the Treatment of Polycystic Ovary Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT06823830 Org: User:
Start: 09/01/23 End: 02/28/25 Due: 02/28/26

Reason Evaluation of Initial Treatment Failure in Patients With CAP

Phase: N/A Priority: Normal
NCT ID: NCT03280004 Org: User:
Start: 11/20/17 End: 11/30/19 Due: 11/30/20

ZR-MTX for PIOL Phase II Trial

Phase: N/A Priority: Normal
NCT ID: NCT06973811 Org: User:
Start: 05/10/25 End: 10/30/29 Due: 10/30/30

The Investigation of the Mechanism of Cachexia Occurrence for Patients With Gastrointestinal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04594863 Org: User:
Start: 11/01/20 End: 06/01/21 Due: 06/01/22

Efficacy and Safety of Avatrombopag in Cancer Patients With Thrombocytopenia

Phase: N/A Priority: Normal
NCT ID: NCT04896528 Org: User:
Start: 06/06/21 End: 12/31/21 Due: 12/31/22

Application of 68Ga NEB PET Imaging in the Diagnosis and Evaluation of Lymphatic Disorders

Phase: N/A Priority: Normal
NCT ID: NCT04273334 Org: User:
Start: 10/01/19 End: 12/31/22 Due: 12/31/23

Luspatercept Plus CsA vs CsA for the Treatment of Newly Diagnosed Non-Transfusion-Dependent NSAA

Phase: N/A Priority: Normal
NCT ID: NCT06424639 Org: User:
Start: 05/31/24 End: 12/31/25 Due: 12/31/26

Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02097459 Org: User:
Start: 03/31/14 End: - Due: -

An Observational Cohort Study to Establish Accurate Nutrition Therapy for Critically Ill Patients

Phase: N/A Priority: Normal
NCT ID: NCT02831725 Org: User:
Start: 07/31/16 End: 07/31/19 Due: 07/31/20

Effect of Virtual Reality (VR) on Pain Relieve During Colonoscopy

Phase: N/A Priority: Normal
NCT ID: NCT06279481 Org: User:
Start: 05/01/24 End: 12/31/24 Due: 12/31/25

Exploring the Application of 3D Bioprinting for Personalized Treatment in Pancreatic Ductal Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05955092 Org: User:
Start: 12/01/22 End: 09/30/24 Due: 09/30/25

The Critical Threshold of Pulse Oximetry Plethysmographic Waveform Parameters in High Quality CPR

Phase: N/A Priority: Normal
NCT ID: NCT03754946 Org: User:
Start: 09/01/15 End: 12/31/18 Due: 12/31/19

Effects of Tianqi Capsule on Glucose Variability in Patients With Type 2 Diabetes.

Phase: N/A Priority: Normal
NCT ID: NCT02617732 Org: User:
Start: 01/31/16 End: 02/28/18 Due: 02/28/19

In-depth Survey for the Reasons of Weight Control Difficulties

Phase: N/A Priority: Normal
NCT ID: NCT06671522 Org: User:
Start: 09/07/24 End: 12/31/24 Due: 12/31/25

Vinorelbine and Ifosfamide as Third-line Treatment for Refractory Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01752517 Org: User:
Start: 12/31/12 End: 12/31/15 Due: 12/31/16

Efficacy and Safety of Telitacicept in Early SLE

Phase: N/A Priority: Normal
NCT ID: NCT05899907 Org: User:
Start: 09/01/22 End: 09/01/25 Due: 09/01/26

Study of Chemotherapy Sequenced by or Combined With EGFR-TKIs for NSCLC Patients Failed to EGFR-TKIs Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01746277 Org: User:
Start: 10/31/12 End: 06/30/16 Due: 06/30/17

Effect of Initial Empirical PEEP Setting on the Esophageal Pressure-guided PEEP Titration in ARDS

Phase: N/A Priority: Normal
NCT ID: NCT05442073 Org: User:
Start: 03/01/22 End: 06/29/22 Due: 06/29/23

Venetoclax in Combination With Standard Induction and Consolidation Chemotherapy in Newly Diagnosed Young AML Patients

Phase: N/A Priority: Normal
NCT ID: NCT06162325 Org: User:
Start: 01/21/22 End: 12/31/25 Due: 12/31/26